AbCellera Biologics Inc.
AbCellera Biologics Inc.
World Rank (Jan-05-2024)
6,216
Market Cap (Jan-05-2024)
1.724 Billion USD
World Rank (Jul-30-2023)
5,362
Market Cap (Jul-30-2023)
2.220 Billion USD
World Rank (Jan-07-2022)
4,491
Market Cap (Jan-07-2022)
3.328 Billion USD
World Rank (Jan-01-2021)
1,590
Market Cap (Jan-01-2021)
10.832 Billion USD
Company Rank in Country in 2023
Rank in Canada in July-2023 is 169
Headquarters Country
Nasdaq / NYSE Code
ABCL
Market Cap (Mar-08-2026)
1.02
Employee Count
174
Employee Count as of Date
As on 2020
Headquarters City/State
World Region
World Subregion
Annual Revenue in USD
288 Million USD
Annual Net Income in USD
118 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
1,013 Million USD
Total Liabilities in USD
225 Million USD
Total Equity in USD
788 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Company Website
Wikipedia
Ads